期刊
DIABETES
卷 67, 期 4, 页码 674-686出版社
AMER DIABETES ASSOC
DOI: 10.2337/db17-1114
关键词
-
资金
- Robert and Janice McNair Foundation
- National Institute for Health Research [1R01AG040110]
- Diabetes Research Center of the Baylor College of Medicine [DRC-P30-DK-079638]
The proliferative response of non-beta islet endocrine cells in response to type 1 diabetes (T1D) remains undefined. We quantified islet endocrine cell proliferation in a large collection of nondiabetic control and T1D human pancreata across a wide range of ages. Surprisingly, islet endocrine cells with abundant proliferation were present in many adolescent and young-adult T1D pancreata. But the proliferative islet endocrine cells were also present in similar abundance within control samples. We queried the proliferating islet cells with antisera against various islet hormones. Although pancreatic polypeptide, somatostatin, and ghrelin cells did not exhibit frequent proliferation, glucagon-expressing alpha-cells were highly proliferative in many adolescent and young-adult samples. Notably, alpha-cells only comprised a fraction (similar to 1/3) of the proliferative islet cells within those samples; most proliferative cells did not express islet hormones. The proliferative hormone-negative cells uniformly contained immunoreactivity for ARX (indicating alpha-cell fate) and cytoplasmic Sox9 (Sox9(Cyt)). These hormone-negative cells represented the majority of islet endocrine Ki67+ nuclei and were conserved from infancy through young adulthood. Our studies reveal a novel population of highly proliferative ARX+ Sox9(Cyt) hormone-negative cells and suggest the possibility of previously unrecognized islet development and/or lineage plasticity within adolescent and adult human pancreata.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据